IGHG3 and myeloid sarcoma: We further propose that (1) serum antibodies exert primary and pathogenic effects in MS development; (2) increased IgG1 and IgG3 result in enhanced cytotoxicity to CNS cells and produce antibody-mediated injury in MS pathogenesis (Figure 1).